The State of Longevity

Consumers are taking more control of their health, and companies that help people act on their health data over time are likely to capture some of the biggest opportunities in longevity. The COVID-19 pandemic and ChatGPT accelerated this shift. A survey of 500 randomly selected U.S. consumers found that 63% know about microplastics in the body, 62% would pay more for products labeled "non-toxic," and 54% use a wearable. Unapproved peptides such as BPC-157 are drawing interest despite missing strong human safety and efficacy data, while the text expects growth in FDA-regulated peptide drugs.